ConductScience.org, home

Paper41524971

AI-driven peptide discovery for endometrial cancer: deep generative modeling and molecular simulation in the big data era.

Fatima I and 8 others. J Comput Aided Mol Des, 2026. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. AI-driven peptide discovery for endometrial cancer: deep generative modeling and molecular simulation in the big data era. Papers, record 41524971. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41524971

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
AI-driven peptide discovery for endometrial cancer: deep generative modeling and molecular simulation in the big data era.
PubMed
Journal
J Comput Aided Mol Des
PubMed
Year
2026
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
3
iCite
Revised in PubMed
2026-11-05
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fatima IIsrar
2Rehman AAbdur
3Wang ZZhibo
4Ur Rehman HHafeez
5Aldaw MMohamed
6Warraich DADawood Ahmed
7Meng YYuxuan
8Li YYan
9Liao MMingzhi

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Endometrial NeoplasmsMajor topic
PeptidesMajor topic
Drug DiscoveryMajor topic
Artificial IntelligenceMajor topic
Female
Humans
Generative Adversarial Networks
Generative Artificial Intelligence
Deep Learning
Molecular Docking Simulation
Autoencoder
beta Catenin
Reinforcement Machine Learning
Proto-Oncogene Proteins c-akt
Molecular Dynamics Simulation
Drug Design

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
62072377National Natural Science Foundation of ChinaPubMed

Source PubMed

Download CSV of grants

References65

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132508653Discovering Anti-Cancer Drugs via Computational Methods.Front Pharmacol2020https://conductscience.org/library/papers/32508653PubMed
239605829Therapeutic peptide development revolutionized: Harnessing the power of artificial intelligence for drug discovery.Heliyon2024https://conductscience.org/library/papers/39605829PubMed
337337978FIGO staging of endometrial cancer: 2023.Int J Gynaecol Obstet2023https://conductscience.org/library/papers/37337978PubMed
433983732Target-Based Evaluation of "Drug-Like" Properties and Ligand Efficiencies.J Med Chem2021https://conductscience.org/library/papers/33983732PubMed
533507815Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline.J Clin Oncol2021https://conductscience.org/library/papers/33507815PubMed
628822813Reinforcement learning-based control of drug dosing for cancer chemotherapy treatment.Math Biosci2017https://conductscience.org/library/papers/28822813PubMed
730096949Modeling Endometrial Cancer: Past, Present, and Future.Int J Mol Sci2018https://conductscience.org/library/papers/30096949PubMed
839480053Beyond Conventional Drug Design: Exploring the Broad-Spectrum Efficacy of Antimicrobial Peptides.Chem Biodivers2025https://conductscience.org/library/papers/39480053PubMed
934531006Deep Reinforcement Learning for Fractionated Radiotherapy in Non-Small Cell Lung Carcinoma.Artif Intell Med2021https://conductscience.org/library/papers/34531006PubMed
1036040035Arteannuin B Enhances the Effectiveness of Cisplatin in Non-Small Cell Lung Cancer by Regulating Connexin 43 and MAPK Pathway.Am J Chin Med2022https://conductscience.org/library/papers/36040035PubMed
1132914015De Novo ESR1 Hotspot Mutation in a Patient With Endometrial Cancer Treated With an Aromatase Inhibitor.JCO Precis Oncol2019https://conductscience.org/library/papers/32914015PubMed
1235936396A Generative Approach to Materials Discovery, Design, and Optimization.ACS Omega2022https://conductscience.org/library/papers/35936396PubMed
1334393317Machine Learning in Drug Discovery: A Review.Artif Intell Rev2022https://conductscience.org/library/papers/34393317PubMed
1440054129Controversies in the management of grade 1 and 2 endometrioid carcinoma of the ovary and uterus.Int J Gynecol Cancer2025https://conductscience.org/library/papers/40054129PubMed
1534699719Generative Deep Learning for Targeted Compound Design.J Chem Inf Model2021https://conductscience.org/library/papers/34699719PubMed
1635510835Reinforcement learning for systems pharmacology-oriented and personalized drug design.Expert Opin Drug Discov2022https://conductscience.org/library/papers/35510835PubMed
1736093931Adherence to the World Cancer Research Fund/American Institute for Cancer Research recommendations and endometrial cancer risk: a multicentric case-control study.Br J Nutr2023https://conductscience.org/library/papers/36093931PubMed
1828006993The structural modification of natural products for novel drug discovery.Expert Opin Drug Discov2017https://conductscience.org/library/papers/28006993PubMed
1936158077Cisplatin for cancer therapy and overcoming chemoresistance.Heliyon2022https://conductscience.org/library/papers/36158077PubMed
2035531470The Role of CTNNB1 in Endometrial Cancer.Dis Markers2022https://conductscience.org/library/papers/35531470PubMed

See all 65 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42366266Integrating artificial intelligence and multi-omics data for precision oncology in endometrial cancer: a narrative review.Funct Integr Genomics2026https://conductscience.org/library/papers/42366266PubMed
42099970Next-Generation Anticancer Peptides: Engineering, Nanotheranostics and Clinical Translation.Nanotheranostics2026https://conductscience.org/library/papers/42099970PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
CTNNB11499PubTator's text mininghttps://conductscience.org/library/genes/1499NCBI Gene
ESR12099PubTator's text mininghttps://conductscience.org/library/genes/2099NCBI Gene
GJA12697PubTator's text mininghttps://conductscience.org/library/genes/2697NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41524971

GET https://conductscience.org/api/papers/v1/41524971/references?page=2